- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02560233
Modulating Stress-Reactivity by Real-Time Multimodal Functional Neuroimaging Based Neurofeedback
February 4, 2020 updated by: University Hospital, Basel, Switzerland
The overall goal of the outlined study is to establish a Real-Time (RT) functional Magnetic Resonance Imaging (fMRI) Neurofeedback (NF) (RT-fMRI-NF) protocol aiming at modulating neural, endocrine, and subjective reactivity to psychosocial stress.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The overall goal of the outlined study is to establish an RT-fMRI-NF protocol aiming at modulating neural, endocrine, and subjective reactivity to psychosocial stress.
More specifically, the investigators pursue the following goals: a) to evaluate whether neural and subjective stress-reactivity can be modified by training volitional control over targeted brain activity by means of RT-fMRI-NF; b) to evaluate whether neuromodulation by means of RT-fMRI-NF can be used as a new way to modulate hormone-release into the periphery; and c) to evaluate whether the efficacy of neuromodulation by RT-fMRI-NF can also be reflected on EEG data as well as the autonomic nervous system (ANS) measured by heart rate variability (HRV).
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 136-713
- Korea University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Sufficient spoken and written knowledge of English
- Right-handedness
- Ability to participate in study procedures
Exclusion Criteria:
- Present or past psychological or psychiatric therapy
- Major or unstable general medical conditions
- Presence of cardiovascular disease
- Current intake of any medication interfering hormonal assessments
- History of major cerebral injury
- Medical MRI contraindication
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Contingent
Contingent RT-fMRI-NF
|
Subjects are provided with contingent RT-fMRI-NF of brain activity in the target region of interest.
|
Sham Comparator: Non-contingent
Sham RT-fMRI-NF
|
Subjects are provided with sham RT-fMRI-NF of brain activity of previously recorded subject.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hypothalamic-pituitary-adrenal (HPA) axis reactivity
Time Frame: At study day one
|
Assessed via salivary cortisol
|
At study day one
|
Blood oxygenation level dependent signal of the target brain region of interest
Time Frame: At study day one
|
Blood oxygenation level dependent (BOLD) signal assessed via functional magnetic resonance imaging, expressed in relative BOLD signal intensity
|
At study day one
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Psychophysiological stress reactivity - blood pressure
Time Frame: At study day one
|
Assessed via blood pressure
|
At study day one
|
Psychophysiological stress reactivity - heart rate variability
Time Frame: At study day one
|
Assessed via heart rate variability
|
At study day one
|
Psychophysiological stress reactivity - heart rate
Time Frame: At study day one
|
Assessed via heart rate
|
At study day one
|
Subjective stress reactivity
Time Frame: At study day one
|
Assessed via Visual Analog Scale
|
At study day one
|
Electrical activity of the brain
Time Frame: At study day one
|
Assessed via electroencephalography (EEG)
|
At study day one
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional connectivity
Time Frame: At study day one
|
Connectivity of brain activity determined by fMRI signal
|
At study day one
|
Feedback on adverse events during the scanner training
Time Frame: At study day one
|
Number of subjects reporting an adverse event
|
At study day one
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Marion Tegethoff, PD Dr., University of Basel
- Principal Investigator: Jong-Hwan Lee, Prof., Korea University
- Principal Investigator: Gunther Meinlschmidt, Prof. Dr., University of Basel; Ruhr-University Bochum
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 1, 2020
Primary Completion (Anticipated)
December 1, 2020
Study Completion (Anticipated)
December 1, 2020
Study Registration Dates
First Submitted
August 10, 2015
First Submitted That Met QC Criteria
September 24, 2015
First Posted (Estimate)
September 25, 2015
Study Record Updates
Last Update Posted (Actual)
February 5, 2020
Last Update Submitted That Met QC Criteria
February 4, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GRNP_2013S1A2A2035364_1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
University of PadovaRecruitingStress | Stress Disorder | Work Related StressItaly
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...Enrolling by invitationStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Duquesne UniversityUniversity of California, San Diego; West Penn Allegheny Health System; El Centro... and other collaboratorsTerminated
-
University of Sao PauloCompleted
-
Dana-Farber Cancer InstituteEnrolling by invitationStress | Post Traumatic Stress Disorder | Work Related StressUnited States
-
Royal Cornwall Hospitals TrustEnrolling by invitationStress | Stress, Psychological | Stress, JobUnited Kingdom
-
Northumbria UniversityVolac International LtdRecruitingStress | Mood | Physiological StressUnited Kingdom
-
Syracuse VA Medical CenterUS Department of Veterans AffairsCompletedEmotional Stress | Psychological Stress | Life StressUnited States
-
Taichung Veterans General HospitalUnknown
Clinical Trials on Contingent RT-fMRI-NF
-
University Hospital, Basel, SwitzerlandKorea University; University of BaselUnknownStress | Mood | Working Memory | MindfulnessSwitzerland, Korea, Republic of
-
University of MichiganBrain & Behavior Research FoundationRecruitingGeneralized Anxiety Disorder | Anxiety | Social Anxiety Disorder | Panic DisorderUnited States
-
Boston VA Research Institute, Inc.Mclean Hospital; Cambridge Health Alliance; Northeastern UniversityRecruitingSchizophrenia | Treatment-resistant Schizophrenia | Auditory HallucinationUnited States
-
Van Boven, Robert W., M.D.Massachusetts Institute of Technology; The Geneva FoundationUnknownTraumatic Brain Injury | Post Traumatic Stress DisorderUnited States
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Korea University; University of BaselCompletedStress | Blood PressureKorea, Republic of
-
Harvard Medical School (HMS and HSDM)CompletedSchizophrenia | Audio Visual Hallucinations | Neurofeedback | Superior Temporal GyrusUnited States
-
Tel-Aviv Sourasky Medical CenterCompletedFibromyalgia (FM)Israel
-
Federal Research Center of Fundamental and Translational...CompletedDepression Moderate | Depression MildRussian Federation
-
University of MinnesotaCompletedAnorexia Nervosa | AnorexiaUnited States